Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

ºÎ½Å °¥»ö¼¼Æ÷Á¾¿¡¼­ »ýÈ­ÇÐÀû °Ë»ç ¹× MIBG ScanÀÇ Áø´ÜÀû À¯¿ë¼º Diagnostic Efficacy of Biochemical Studies and MIBG Scan in Pheochromocytoma

´ëÇѺñ´¢±â°úÇÐȸÁö 1997³â 38±Ç 12È£ p.1291 ~ 1295
¼Ò¼Ó »ó¼¼Á¤º¸
¹ÚÇü±Ù/Hyungkeun Park ±èÁ¤±Õ/È«¹ü½Ä/±èû¼ö/¹ÚÅÂÇÑ/¾ÈÇÑÁ¾/Jung Gyun Kim/Bumsik Hong/Choung Soo Kim/Taehan Park/Han Jong Ahn

Abstract

¼­·Ð
°¥»ö¼¼Æ÷Á¾Àº ½Å°æ´É (neural crest)¿¡¼­ ±â¿øÇÏ´Â Á¾¾ç Áß ºÎ½Å¼öÁú¿¡¼­ ¹ß»ýÇÏ´Â Ä«Å×ÄÝ
¾Æ¹Î-ºÐºñ Á¾¾çÀÌ´Ù ÀÌ Á¾¾çÀº Ä«Å×ÄݾƹΠ¹× ±× ´ë»ç·Î ÀÎÇÏ¿© °íÇ÷¾Ð, µÎÅë, ½É°èÇ×Áø, ¹ß
ÇÑ µîÀÇ ¿©·¯ ¹ßÀÛ¼º Áõ»óÀ» ÀÏÀ¸Å°¸ç ¼ö¼ú·Î½á °íÇ÷¾ÐÀ» Ä¡·áÇÒ ¼ö ÀÖ´Ù´Â Á¡¿¡¼­ ºñ´¢±â
°úÀûÀ¸·Î Áß¿äÇÑ ÁúȯÀÌ´Ù.
Ä¡·á¿¡¼­´Â ƯÈ÷ ¼ö¼ú Áß ¹× ¼ú ÈÄ ºÎÀÛ¿ëÀ» ¿¹¹æÇϱâ À§ÇØ ¼ú Àü óġ°¡ ÇÊ¿äÇÏ¸ç µû¶ó
¼­ ¼ú Àü Áø´ÜÀÌ ÇʼöÀûÀÌ°í, ÀÌ¿¡´Â ÀüÅëÀûÀ¸·Î ÀÓ»óÁõ»ó, »ýÈ­ÇÐÀû °Ë»ç, ¹æ»ç¼±ÇÐÀû °Ë»ç
µîÀÌ ÀÌ¿ëµÇ¾î ¿Ô´Ù.
ÇÑÆí 1980³â´ë¿¡ ¹æ»ç¼± ¿Á¼ÒÇ¥Áö MIBG (Met-aiodobenzylguanidine)°¡ ¼Ò°³µÈ ÀÌÈÄ·Î
ÀüÅëÀûÀÎ Áø´Ü¹æ¹ýÀÇ ´ÜÁ¡À» º¸¿ÏÇÏ¿© ÃÖ±Ù °¥»ö¼¼Æ÷Á¾À» Æ÷ÇÔÇÑ ½Å°æ³»ºÐºñ Á¾¾çÀÇ Áø´Ü¿¡
³Î¸® ÀÌ¿ëµÇ°í ÀÖ´Ù.
ÀÌ¿¡ ÀúÀÚµéÀº °¢ Áø´Ü ¹æ¹ýµéÀÇ À¯¿ë¼º°ú °¡Àå °æÁ¦ÀûÀ̸鼭 È¿°úÀûÀÎ Áø´Ü¹ýÀ» ¾Ë¾Æº¸
°íÀÚ ÇÏ¿´´Ù.
#ÃÊ·Ï#
We evaluated the role of clinical symptoms, biochemical studies and
metaiodobenzylguanidine (MIBG) scan in the diagnosis of pheochromocytoma.
From August 1991 to June 1997, 42 patients with complaints of hypertension or
adrenal mass evaluated with MIBG scan, 24 hot. urinary vanillylmandelic acid (VMA),
serurm and 24 hour urinary catecholamine and radiologic studies such as CT, MRI or
ultrasonography. Initial 9 patients were evaluated with 131 I-MIBG scan and the rest 33
patients with 123 I-MIBG scan.
Of 42 Patients, histologic diagnosis was obtained in 32 patients including 23 patients
with leochromocytoma or paraganglioma and 9 patients with other adrenal or
extra-adrenal tumors. Remaining 10 patients had no evidence of adrenal disease on
radiologic studies. Paroxysmal symptoms or hypertension was noted in 14 patients with
pheochromocytoma or paraganglioma, while it was also found in 12 out of 19 patients
without pheochromocytoma or paraganglioma. sensitivity, specificity and positive
predictive value (PPV) of each diagnostic modality were 60.9%, 92.9% and 93.3% in 24
hour urinary VMA, 61.9%, 75.0%, and 81.3% in 24 hour urinary catecholamine, 82.6%,
94.7%, and 95.0% in MIBG scan, respectively. Sensitivity and specificity were improved
to 86.9% and 100% when 24 hour urinary VMA and MIBG scan were combined.
In conclusion, MIBG scan was the most useful single screening method for the
diagnosis of pheochromocytoma, and combination of MIBG scan and 24 hour urinary
VMA would enhance the diagnostic accuracy.

Å°¿öµå

iodine-123-metaiodobenzylguanidine; Pheochromocytoma; Vanillylmandelic Acid;

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

   

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS